EN | ES | DE | FR | IT | 日本語 | 한국어 | 中文

admin

December 20, 2019

FEDERAL CIRCUIT TO EXAMINE THE STANDING OF INVALIDITY DETERMINATIONS IN PRIOR INTER PARTES REVIEW PROCEEDINGS

  FEDERAL CIRCUIT TO EXAMINE THE STANDING OF INVALIDITY DETERMINATIONS IN PRIOR INTER PARTES REVIEW PROCEEDINGS   By: Emily Gaukstern   On October 31st, 2019 the […]
November 22, 2019

PATENT TRIAL AND APPEAL BOARD HIGHLIGHTS TRAP FOR THE UNWARY

PATENT TRIAL & APPEAL BOARD HIGHLIGHTS TRAP FOR THE UNWARY   By: Milton Oliver A significant portion of patent litigation has shifted, in recent years, from […]
November 6, 2019

POST GRANT PROCEEDINGS SERIES: Is IPR the Best Decision for Me?

POST GRANT PROCEEDINGS SERIES Is IPR the best decision for me?   By: Emily Gaukstern The America Invents Act (AIA), put into effect September 16, 2012, […]
October 7, 2019

CAFC TO HEAR MEDTECH PATENT DISPUTE BETWEEN 23ANDME, INC. V. ANCESTRY.COM DNA, LLC

  CAFC TO HEAR MEDTECH PATENT DISPUTE BETWEEN 23ANDME, INC. V. ANCESTRY.COM DNA, LLC   By: Katie Rubino   On October 2nd, 2019 oral arguments commenced at […]
September 11, 2019

Patent Attorney Milton Oliver Joins Caldwell IP Law Vermont Team

Patent Attorney Milton Oliver Joins Caldwell IP Law Vermont Team     Caldwell IP Law is pleased to announce that Milton Oliver has joined the firm […]
August 27, 2019

Biotech and IP: Financing and Strategy

Biotech and IP: Financing and Strategy For many budding biotech entrepreneurs, the business side of launching a biotech startup can seem foreign and intimidating. While a […]
August 15, 2019

Biotech and IP: Getting Started

Launching your biotech start-up is an exciting, albeit overwhelming, venture. Eager entrepreneurs often struggle to navigate the labyrinth of tasks necessary to getting a startup off the […]
July 29, 2019

CAFC Rules Suboxone Patent is Not Infringed by Generic Buprenorphine Film Product

  CAFC Rules Suboxone Patent is Not Infringed by Generic Buprenorphine Film Product   By: Katie Rubino   Recently on July 9th the Court of Appeals for […]
July 8, 2019

Patent Strategies for Small Molecule Drugs versus Biological Drugs

  Patent Strategies for Small Molecule Drugs Versus Biological Drugs   By: Katie Rubino   Molecules used as drug products are often categorized into two classes: small […]
June 11, 2019

CAFC Affirms Invalidation of Oxycodone Patent for Lack of Written Description

CAFC Affirms Invalidation of Oxycodone Patent for Lack of Written Description   By: Katie Rubino   On April 19th, 2019 the Court of Appeals of the Federal […]